Novo Nordisk A/s

(CPSE) NOVO B

Current Price$0.00

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

Novo Nordisk A/s Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$327.80K

Net Income (TTM)

$121.96K

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

NOVO B News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Nordisk A/s

Industry

Pharmaceuticals

Sector

Health Care

Employees

68,794

CEO

Maziar Mike Doustdar

Website

www.novonordisk.com

NOVO B Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Novo Nordisk A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$96.82K

+1.2%

Gross Profit

$83.22K

+1.3%

Gross Margin

85.96%

+1.0%

Market Cap

N/A

Market Cap/Employee

$14.92

+0.5%

Employees

68,794

+0.9%

Net Income

$48.56K

+1.7%

EBITDA

$63.26K

+1.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$21.13K

+0.5%

Accounts Receivable

$82.56K

+1.2%

Inventory

$51.35K

+1.2%

Long Term Debt

$119.17K

+1.2%

Short Term Debt

$27.21K

+1.2%

Return on Assets

23.27%

+0.9%

Return on Invested Capital

50.09%

+0.9%

Free Cash Flow

$12.09K

+0.4%

Operating Cash Flow

$23.41K

+0.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7339.78-0.00%

^DJIDJI

^DJIDJI$49639.86-0.01%

^IXICNASDAQ

^IXICNASDAQ$25826.30-0.00%

BTCBitcoin

BTCBitcoin$80138.00-0.02%

AAPLAAPL

AAPLAAPL$288.76+0.00%

AMZNAMZN

AMZNAMZN$272.73-0.01%

GOOGGOOG

GOOGGOOG$394.42-0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.35-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.18+0.02%

IRENIren

IRENIren$56.85-0.07%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

Questions About NOVO B

What is the current price of Novo Nordisk A/s?

Novo Nordisk A/s is trading at N/A per share.

What is the 52-week range for Novo Nordisk A/s?

Over the past 52 weeks, Novo Nordisk A/s has traded between N/A and N/A.

How much debt does Novo Nordisk A/s have?

As of the most recent reporting period, Novo Nordisk A/s reported total debt of $146.38B.

How much cash does Novo Nordisk A/s have on hand?

Novo Nordisk A/s reported $21.13B in cash and cash equivalents in its most recent financial results.

What is Novo Nordisk A/s’s dividend yield?

Novo Nordisk A/s does not currently have a dividend yield.

Novo Nordisk A/s

Novo Nordisk A/s Financials at a Glance

NOVO B News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Novo Nordisk A/s

NOVO B Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Novo Nordisk A/s Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NOVO B

What is the current price of Novo Nordisk A/s?

What is the 52-week range for Novo Nordisk A/s?

How much debt does Novo Nordisk A/s have?

How much cash does Novo Nordisk A/s have on hand?

What is Novo Nordisk A/s’s dividend yield?

Premium Investing Services